Eliav Shaked's guest appearances

Eliav Shaked

It's about the triple aim!

Empowered Patient Podcast

HealthBiz with David E. Williams

OwlTail

Eliav Shaked is a biomedical engineer from Israel who once worked at a summer camp in upstate New York. A favorite staffer there developed dementia and went downhill so fast that Eliav couldn’t even visit her. That’s when he decided to focus his talents on early detection of Alzheimer’s Disease. RetiSpec --short for retinal spectroscopy, is an innovative imaging company using artificial intelligence to detect neurodegenerative diseases. Eliav co-founded the company and is its CEO. Support the showHost David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

Eliav Shaked is a biomedical engineer from Israel who once worked at a summer camp in upstate New York. A favorite staffer there developed dementia and went downhill so fast that Eliav couldn’t even visit her. That’s when he decided to focus his talents on early detection of Alzheimer’s Disease. RetiSpec --short for retinal spectroscopy, is an innovative imaging company using artificial intelligence to detect neurodegenerative diseases. Eliav co-founded the company and is its CEO. <a href="https://www.buzzsprout.com/1367974/support" rel="payment nofollow" target="_blank">Support the show</a>Host <a href="https://www.linkedin.com/in/davideugenewilliams/" rel="nofollow" target="_blank">David E. Williams</a> is president of healthcare strategy consulting firm <a href="https://www.healthbusinessgroup.com/" rel="nofollow" target="_blank">Health Business Group</a>. Produced by <a href="https://www.linkedin.com/in/dafna-williams-53aaa7199/" rel="nofollow" target="_blank">Dafna Williams</a>.

Alzheimer's diagnosis via retinal scan. Interview with RetiSpec CEO Eliav Shaked

Catherine Bornbaum RetiSpec

Eliav Shaked, CEO, and Catherine Bornbaum, Head of Clinical Operations and Partnerships at RetiSpec are using hyperspectral retinal imaging to find more accurate and earlier biomarkers of neurodegenerative diseases. As part of a regular eye exam, this non-invasive test can be administered by an ophthalmologist or optometrist using existing retinal cameras with the data being analyzed using AI to identify unique molecule signatures. Eliav explains, "What's unique about hyperspectral imaging or specifically hyperspectral retinal imaging is the fact that it's a tool that measures different coloring of elements in a much more detailed way. So, while we humans are limited to seeing and interpreting only three colors, hyperspectral retinal imaging can cover more than a hundred different colors in a very precise way. And it's really our way to get much more content from the back of the eye. And what RetiSpec is doing with that data is we're integrating our very own artificial intelligence that allows us to recognize patterns that no human eye can see." Catherine elaborates, "We are focused right now on identifying the markers for Alzheimer's disease through this hyperspectral retinal imaging. But because of the close connection between the retina and the brain, we believe that there are also a number of other indications and specifically neurologic conditions that can be detected using this approach for things like ALS, MS, Parkinson's disease, CTE, and a number of conditions." @RetiSpec @EliavShaked @CathBornbaum #RetiSpec #EarlyAlzheimersDetection #AlzheimersDisease #RetinalScans #HyperspectralImaging RetiSpec.com Download the transcript here

Eliav Shaked, CEO, and Catherine Bornbaum, Head of Clinical Operations and Partnerships at RetiSpec are using hyperspectral retinal imaging to find more accurate and earlier biomarkers of neurodegenerative diseases. As part of a regular eye exam, this non-invasive test can be administered by an ophthalmologist or optometrist using existing retinal cameras with the data being analyzed using AI to identify unique molecule signatures. Eliav explains, "What's unique about hyperspectral imaging or specifically hyperspectral retinal imaging is the fact that it's a tool that measures different coloring of elements in a much more detailed way. So, while we humans are limited to seeing and interpreting only three colors, hyperspectral retinal imaging can cover more than a hundred different colors in a very precise way. And it's really our way to get much more content from the back of the eye. And what RetiSpec is doing with that data is we're integrating our very own artificial intelligence that allows us to recognize patterns that no human eye can see." Catherine elaborates, "We are focused right now on identifying the markers for Alzheimer's disease through this hyperspectral retinal imaging. But because of the close connection between the retina and the brain, we believe that there are also a number of other indications and specifically neurologic conditions that can be detected using this approach for things like ALS, MS, Parkinson's disease, CTE, and a number of conditions." @RetiSpec @EliavShaked @CathBornbaum #RetiSpec #EarlyAlzheimersDetection #AlzheimersDisease #RetinalScans #HyperspectralImaging <a href="http://RetiSpec.com" rel="noopener nofollow" target="_blank">RetiSpec.com</a> <a href="http://empoweredpatientradio.com/early-detection-of-alzheimers-using-hyperspectral-retinal-imaging-with-eliav-shaked-and-catherine-bornbaum-retispec-transcript" rel="noopener nofollow" target="_blank">Download the transcript here</a><a href="http://RetiSpec.com" rel="noopener nofollow" target="_blank"></a>

Early Detection of Alzheimer’s Using Hyperspectral Retinal Imaging with Eliav Shaked and Catherine Bornbaum RetiSpec

Sourced from DOCSF 2018 Health Innovation Media co-host Nick Adkins @NickisnPDX cathes up Eliav Shaked, M.Sc, CEO and Co-founder of Retispec (@retispec). Retispec's mission is 'to enable and promote widespread early detection of Alzheimer’s Disease pathology.'DOCSF is: Bridging: Technology + Orthopaedics and it's mission is:to unite innovators and health care leaders  to adopt and integrate digital health solutions in musculoskeletal care. The goal of  our alliance is to create meaningful and measurable improvements in quality, cost and access in musculoskeletal verticals. DOCSF’s vision is to create a movement that delivers digital health (lower cost, higher quality and better access) by focusing on technology within musculoskeletal care.Organized by the visionary Stefano Bini, MD (@sbiniMD) Founder and Chair, The Digital Orthopedics Conference, and Professor of Orthopaedics UCSF and hosted during the JP Morgan Healthcare Conference week in San Francisco, the conference brought together physicians, other clinicians, informaticists, entreprenuers, academics, thought leaders, suppliers and vendors with an interest in advancing the deployment and value proposition of technology into the practice of orthopedics.

Sourced from DOCSF 2018 Health Innovation Media co-host Nick Adkins @NickisnPDX cathes up Eliav Shaked, <a href="http://M.Sc" rel="nofollow" target="_blank">M.Sc</a>, CEO and Co-founder of Retispec (@retispec). Retispec's mission is 'to enable and promote widespread early detection of Alzheimer’s Disease pathology.' DOCSF is: Bridging: Technology + Orthopaedics and it's mission is: to unite innovators and health care leaders  to adopt and integrate digital health solutions in musculoskeletal care. The goal of  our alliance is to create meaningful and measurable improvements in quality, cost and access in musculoskeletal verticals. DOCSF’s vision is to create a movement that delivers digital health (lower cost, higher quality and better access) by focusing on technology within musculoskeletal care. Organized by the visionary Stefano Bini, MD (@sbiniMD) Founder and Chair, The Digital Orthopedics Conference, and Professor of Orthopaedics UCSF and hosted during the JP Morgan Healthcare Conference week in San Francisco, the conference brought together physicians, other clinicians, informaticists, entreprenuers, academics, thought leaders, suppliers and vendors with an interest in advancing the deployment and value proposition of technology into the practice of orthopedics.